izpis_h1_title_alt

A dual biomarker TK1 protein and CA125 or HE4-based algorithm as a better diagnostic tool than ROMA Index in early detection of ovarian cancer
ID Cviič, Diana (Author), ID Jagarlamudi, K. K. (Author), ID Meglič, Leon (Author), ID Škof, Erik (Author), ID Zore, Andrej (Author), ID Lukanovič, David (Author), ID Eriksson, Staffan (Author), ID Osredkar, Joško (Author)

.pdfPDF - Presentation file, Download (3,69 MB)
MD5: 115C4641B76C0BBEDA11E046033B9D9D
URLURL - Source URL, Visit https://www.mdpi.com/2072-6694/15/5/1593 This link opens in a new window

Abstract
Background: The early detection of ovarian cancer is presently not effective, and it is crucial to establish biomarkers for the early diagnosis of ovarian cancer to improve the survival of patients. Materials and methods: The aim of this study was to investigate the role of thymidine kinase 1 (TK1) in combination with CA 125 or HE4 to serve as a potential diagnostic biomarkers for ovarian cancer. In this study, a set of 198 serum samples consisting of 134 ovarian tumor patients and 64 healthy age-matched controls were analyzed. The TK1 protein levels in serum samples were determined using the AroCell TK 210 ELISA. Results: A combination of TK1 protein with CA 125 or HE4 showed better performance than either of them alone in the differentiation of early stage ovarian cancer from the healthy control group, but also a significantly better performance than the ROMA index. However, this was not observed using a TK1 activity test in combination with the other markers. Furthermore, the combination of TK1 protein and CA 125 or HE4 could differentiate early stage disease (stage I, II) more efficiently from advanced-stage (stage III, IV) disease (p < 0.0001). Conclusions: The combination of TK1 protein with CA 125 or HE4 increased the potential of detecting ovarian cancer at early stages.

Language:English
Keywords:thymidine kinase 1, TK 210 ELISA, TK-liaison, CA 125, HE4, ROMA index, ovarian cancer
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FFA - Faculty of Pharmacy
MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2023
Number of pages:18 str.
Numbering:Vol. 15, iss. 5, art. 1593
PID:20.500.12556/RUL-144644 This link opens in a new window
UDC:612.621:616-006
ISSN on article:2072-6694
DOI:10.3390/cancers15051593 This link opens in a new window
COBISS.SI-ID:144061955 This link opens in a new window
Publication date in RUL:06.03.2023
Views:579
Downloads:77
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Cancers
Shortened title:Cancers
Publisher:MDPI
ISSN:2072-6694
COBISS.SI-ID:517914137 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:timidin kinaza 1, indeks ROMA

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back